← All updates
Public health

Pediatrics · Public Health · 3 h ago

ECDC models estimate RSV immunisation could reduce infant hospitalisations

An ECDC multi-model assessment estimated the potential effect of RSV immunisation on infant hospitalisations across the EU/EEA. With 90% of newborns receiving long-acting monoclonal antibodies at birth, models projected a 61% reduction in RSV-related hospitalisations during the first two months of life; maternal vaccination was projected to reduce them by 52%.

The European Centre for Disease Prevention and Control (ECDC) reported a multi-model assessment of strategies to reduce RSV-related hospitalisations among infants in the EU/EEA. The models considered vaccination during pregnancy and direct infant immunisation with long-acting monoclonal antibodies.

Assuming 90% of newborns receive monoclonal antibodies at birth, the models projected that 61% of RSV-related hospitalisations in infants could be prevented during the first two months of life. The assessment estimated a 52% reduction over the same period with universal vaccination of pregnant mothers.

These are modelled estimates, not observed outcomes from an immunisation programme. The source does not provide further details on model inputs or uncertainty, and the projections depend on the stated coverage assumption. The report indicates potential population-level effects but does not establish the effectiveness of a specific product or provide evidence that should by itself prompt changes in clinical practice.

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →

Source

European Centre for Disease Prevention and Control: As the cold season nears, immunisation of newborns against universal RSV could significantly reduce infant hospitalisations across Europe ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.